| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-06-4418 |
| P698 | PubMed publication ID | 18172293 |
| P50 | author | Mingyong Luo | Q80438545 |
| P2093 | author name string | Fang Zhou | |
| Ning Li | |||
| Xiaoli Feng | |||
| Liang Zhang | |||
| Jing Cheng | |||
| Jie He | |||
| Yong Guo | |||
| Xi Ma | |||
| Xin Meng | |||
| Keith Mitchelson | |||
| Bin Qiu | |||
| Kang Shao | |||
| Susheng Shi | |||
| Zhaoli Chen | |||
| Baozhong Li | |||
| P433 | issue | 1 | |
| P921 | main subject | esophageal squamous cell carcinoma | Q108442577 |
| squamous cell carcinoma | Q681817 | ||
| P304 | page(s) | 26-33 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma | |
| P478 | volume | 68 |
| Q49378696 | A 10‑microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods |
| Q90444182 | A 3-miRNA signature predicts survival of patients with hypopharyngeal squamous cell carcinoma after post-operative radiotherapy |
| Q45334190 | A deep ensemble model to predict miRNA-disease association |
| Q54417122 | A functional varient in microRNA-146a is associated with risk of esophageal squamous cell carcinoma in Chinese Han |
| Q35123099 | A microRNA signature predicts survival in early stage small-cell lung cancer treated with surgery and adjuvant chemotherapy |
| Q34550603 | A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. |
| Q55000594 | ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer. |
| Q89718150 | Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population |
| Q33649478 | Biochip System for Rapid and Accurate Identification of Mycobacterial Species from Isolates and Sputum |
| Q38504025 | Biological role of microRNA-103 based on expression profile and target genes analysis in pigs. |
| Q34205596 | Biomarkers for Colorectal Cancer |
| Q34989307 | Cell-specific post-transcriptional regulation of γ-synuclein gene by micro-RNAs |
| Q37108418 | Characterization and expression profiles of miRNAs in rice seeds |
| Q36670660 | Circulating human cytomegalovirus-encoded HCMV-miR-US4-1 as an indicator for predicting the efficacy of IFNα treatment in chronic hepatitis B patients |
| Q37447965 | Circulating miRNA profile in esophageal adenocarcinoma |
| Q35108381 | Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma |
| Q33867325 | Circulating microRNAs: novel biomarkers for esophageal cancer |
| Q36326374 | Circulating small non-coding RNA signature in head and neck squamous cell carcinoma |
| Q24289183 | Clinical outcome prediction by microRNAs in human cancer: a systematic review |
| Q37188178 | Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients |
| Q33890984 | Comparison of long non‑coding RNAs, microRNAs and messenger RNAs involved in initiation and progression of esophageal squamous cell carcinoma |
| Q31028108 | Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers |
| Q34048027 | Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer |
| Q36211811 | DNA Microarray Detection of 18 Important Human Blood Protozoan Species |
| Q34037931 | Derivation of rhesus monkey parthenogenetic embryonic stem cells and its microRNA signature |
| Q33481633 | Detection of cancer with serum miRNAs on an oligonucleotide microarray |
| Q35447762 | Developing a prognostic micro-RNA signature for human cervical carcinoma |
| Q35126364 | Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma |
| Q42149502 | Differential expression of miRNAs in esophageal cancer tissue |
| Q34988888 | Dissection of miRNA-miRNA interaction in esophageal squamous cell carcinoma |
| Q83640785 | Down-regulation of miR-141 in gastric cancer and its involvement in cell growth |
| Q39809297 | Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer |
| Q39121756 | Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells |
| Q35716165 | Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma |
| Q38093059 | Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma |
| Q28076178 | Esophageal Cancer in Golestan Province, Iran: A Review of Genetic Susceptibility and Environmental Risk Factors |
| Q34143366 | Expression Profile of MicroRNAs in Serum: A Fingerprint for Esophageal Squamous Cell Carcinoma |
| Q37407324 | Expression of MMP9, SERPINE1 and miR-134 as prognostic factors in esophageal cancer |
| Q36232238 | Five miRNAs Considered as Molecular Targets for Predicting Esophageal Cancer. |
| Q33433032 | Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy |
| Q34138043 | Genetic variation in microRNA genes and prostate cancer risk in North Indian population |
| Q34920257 | Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk |
| Q26751068 | Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers |
| Q33483656 | Identification and characterization of novel amphioxus microRNAs by Solexa sequencing |
| Q64093262 | Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance |
| Q28395462 | Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot study |
| Q33508032 | Identification of novel stress-regulated microRNAs from Oryza sativa L. |
| Q36424106 | Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling |
| Q64053093 | Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs |
| Q64232910 | Identifying the differentially expressed microRNAs in esophagus squamous cell carcinoma of Kazakh patients in Xinjiang |
| Q33575734 | Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways |
| Q94585044 | Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis |
| Q38752754 | Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer |
| Q35789394 | Integrative genomics analysis of genes with biallelic loss and its relation to the expression of mRNA and micro-RNA in esophageal squamous cell carcinoma |
| Q37091936 | Intercellular communication by exosome-derived microRNAs in cancer |
| Q36356051 | Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma. |
| Q41980198 | Low expression of miR-1469 predicts disease progression and unfavorable post-surgical clinical outcomes in patients with esophageal squamous cell cancer |
| Q35673479 | Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192. |
| Q33494538 | MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. |
| Q88567734 | MiR-149 sensitizes esophageal cancer cell lines to cisplatin by targeting DNA polymerase β |
| Q39271161 | MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. |
| Q37457633 | MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma. |
| Q35835255 | MiR-21/miR-375 ratio is an independent prognostic factor in patients with laryngeal squamous cell carcinoma |
| Q37046835 | MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2. |
| Q47782707 | MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis |
| Q87351725 | MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma |
| Q34780990 | MiR-467a is upregulated in radiation-induced mouse thymic lymphomas and regulates apoptosis by targeting Fas and Bax. |
| Q38854866 | MiR-499 Enhances the Cisplatin Sensitivity of Esophageal Carcinoma Cell Lines by Targeting DNA Polymerase β. |
| Q34469548 | MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. |
| Q39572326 | MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells |
| Q26823077 | Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies |
| Q33973612 | MicroRNA analysis of microdissected normal squamous esophageal epithelium and tumor cells |
| Q37988359 | MicroRNA and its roles in esophageal cancer. |
| Q41928691 | MicroRNA expression and its detection in human supraglottic laryngeal squamous cell carcinoma |
| Q34008617 | MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs |
| Q34102917 | MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival |
| Q21283751 | MicroRNA expression profiling during the life cycle of the silkworm (Bombyx mori) |
| Q37160342 | MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma |
| Q37350288 | MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma |
| Q37944970 | MicroRNA involvement in esophageal carcinogenesis |
| Q33748980 | MicroRNA profiles discriminate among colon cancer metastasis |
| Q37208449 | MicroRNA profiling and head and neck cancer |
| Q48513587 | MicroRNA-1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib |
| Q54987304 | MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma. |
| Q89909208 | MicroRNA-103a-3p potentiates chemoresistance to cisplatin in non-small cell lung carcinoma by targeting neurofibromatosis 1 |
| Q28748642 | MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines |
| Q53030138 | MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer. |
| Q39426030 | MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways |
| Q89908241 | MicroRNA-146a as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma |
| Q39329822 | MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma. |
| Q41898973 | MicroRNA-34b has an oncogenic role in esophageal squamous cell carcinoma |
| Q58561314 | MicroRNA-365 suppresses cell growth and invasion in esophageal squamous cell carcinoma by modulating phosphoserine aminotransferase 1 |
| Q53309576 | MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. |
| Q33751069 | MicroRNA-375 suppresses esophageal cancer cell growth and invasion by repressing metadherin expression |
| Q38815837 | MicroRNA-506 inhibits esophageal cancer cell proliferation via targeting CREB1. |
| Q34956599 | MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma |
| Q43485323 | MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma. |
| Q35949461 | MicroRNAs and Gastroenterological Cancers |
| Q36097056 | MicroRNAs and esophageal cancer |
| Q38218553 | MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. |
| Q36422143 | MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders |
| Q39177667 | MicroRNAs related polymorphisms and genetic susceptibility to esophageal squamous cell carcinoma |
| Q21267200 | MicroRNAs show diverse and dynamic expression patterns in multiple tissues of Bombyx mori |
| Q45366262 | MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. |
| Q33786949 | MicroRNAs: critical mediators of differentiation, development and disease |
| Q37737601 | MicroRNAs: novel biomarkers for gastrointestinal carcinomas |
| Q39605990 | Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. |
| Q33927250 | Mir-34a is upregulated during liver regeneration in rats and is associated with the suppression of hepatocyte proliferation |
| Q33643722 | Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma |
| Q38134029 | Molecular alterations and clinical relevance in esophageal squamous cell carcinoma |
| Q36324801 | Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma |
| Q33597366 | None-endoscopic Screening for Esophageal Squamous Cell Carcinoma- A Review |
| Q37551112 | Original Research: miR-194 inhibits proliferation and invasion and promotes apoptosis by targeting KDM5B in esophageal squamous cell carcinoma cells |
| Q36962403 | Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11). |
| Q35944720 | Pathogenesis of glucocorticoid-induced avascular necrosis: A microarray analysis of gene expression in vitro |
| Q34354560 | Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma |
| Q36309542 | Plasma microRNAs to predict the response of radiotherapy in esophageal squamous cell carcinoma patients |
| Q35222337 | Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer |
| Q37367717 | Potential diagnostic implications of miR-144 overexpression in human oesophageal cancer |
| Q35225642 | Prediction of long noncoding RNA functions with co-expression network in esophageal squamous cell carcinoma |
| Q24612881 | Prognostic significance of differentially expressed miRNAs in esophageal cancer |
| Q59793913 | Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC) |
| Q92024244 | Reduced miR-203 predicts metastasis and poor survival in esophageal carcinoma |
| Q33587316 | Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients. |
| Q41785826 | Relevance of Rabbit VX2 Tumor Model for Studies on Human Hepatocellular Carcinoma: A MicroRNA-Based Study |
| Q60930861 | Robust analysis of novel mRNA-lncRNA cross talk based on ceRNA hypothesis uncovers carcinogenic mechanism and promotes diagnostic accuracy in esophageal cancer |
| Q34963516 | Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues |
| Q34656109 | Salivary microRNAs as promising biomarkers for detection of esophageal cancer |
| Q35801033 | Sequence, structure, and dynamic determinants of Hsp27 (HspB1) equilibrium dissociation are encoded by the N-terminal domain |
| Q37392819 | Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer |
| Q37448284 | Small RNA: a large contributor to carcinogenesis? |
| Q37185714 | Support vector machine-based nomogram predicts postoperative distant metastasis for patients with oesophageal squamous cell carcinoma |
| Q98224335 | Targeting deubiquitinating enzyme USP26 by microRNA-203 regulates Snail1's pro-metastatic functions in esophageal cancer |
| Q37211907 | The expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma |
| Q24608620 | The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases |
| Q38705592 | The role of microRNA in esophageal squamous cell carcinoma |
| Q35742519 | Two Different Serum MiRNA Signatures Correlate with the Clinical Outcome and Histological Subtype in Pleural Malignant Mesothelioma Patients. |
| Q38931827 | Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma |
| Q37550125 | cDNA microarray analysis of esophageal cancer: discoveries and prospects |
| Q42020455 | hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis. |
| Q36983766 | miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression |
| Q47831440 | miR-125a-5p upregulation suppresses the proliferation and induces the cell apoptosis of lung adenocarcinoma by targeting NEDD9. |
| Q64901256 | miR-196a regulates the proliferation, invasion and migration of esophageal squamous carcinoma cells by targeting ANXA1. |
| Q34420624 | miR-21 and miR-375 microRNAs as candidate diagnostic biomarkers in squamous cell carcinoma of the larynx: association with patient survival. |
| Q34832407 | miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma |
| Q39283457 | miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma |
| Q42347159 | miR612 is associated with esophageal squamous cell carcinoma development and metastasis, mediated through TP53. |
| Q34623368 | miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers |
| Q46294728 | miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy |
| Q26747138 | miRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature Review |
| Q47778954 | miRNAs as Biomarkers for Predicting the Progression of Ductal Carcinoma in Situ |
| Q40547026 | miRsig: a consensus-based network inference methodology to identify pan-cancer miRNA-miRNA interaction signatures |
| Q36084306 | microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3. |
| Q37587357 | microRNA-155 acts as an oncogene by targeting the tumor protein 53-induced nuclear protein 1 in esophageal squamous cell carcinoma |
| Q38819565 | microRNA-186 inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma by targeting SKP2. |
| Q34695995 | microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin |
Search more.